Letter by Tampaki et al Regarding Article,

Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)".

Tampaki EC Department of Propaedeutic Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, Greece (E.C.T.).
Tampakis A Department of General and Visceral Surgery, Basel University Hospital, Switzerland (A.T.).
Pantos C Department of Pharmacology, National and Kapodistrian University of Athens, Greece (C.P.).